OncoLens, an Atlanta, GA-based company that provides an integration and collaboration platform to cancer centers, received an investment from Cross border Impact Venture Fund.
The amount of the deal was not disclosed.
The company intends to use the funds to expand its domestic and global footprint into regions including rural communities and low-middle income countries where there are needs to add capacity, resources and access to shared expertise to identify the right diagnostics and treatments for patients, as well as support much needed diversity and inclusion in access and research.
Led by CEO Anju Mathew, OncoLens enables multidisciplinary cancer care across the continuum. Through a streamlined, secure HIPAA-compliant infrastructure, it drives intra-enterprise, community, and network participation in multidisciplinary care planning, tracking, and delivery. Patients can collaborate on treatment plans, track quality for accreditation, and alignment to care pathways. As a result, health systems maximize clinical trial participation, an extended referral stream, and the creation of a center of excellence that can be leveraged to support patient care and provider education.
With more than 200 cancer centers in the U.S and clients in the larger EMEA (Europe, Middle East and Africa) region, OncoLens’ network enables cross collaboration between multiple entities whether they are academic center/NCIs (national cancer institutes) and their community affiliates, large integrated delivery networks (IDNs) or across international borders.
FinSMEs
14/07/2023